Suchergebnisse - "Bourgi, Kassem"

PubPharm (27)

1

Preswitch Regimens Influence the Rate of Weight Gain After Switch to Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir (TLD) : Study From an East African Cohort

enthalten in: Open forum infectious diseases | 2023

von Bourgi, K. | Ofner, S. | Musick, B. | +5

2

Weight Gain Among Treatment-Naïve Persons With HIV Receiving Dolutegravir in Kenya

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Bourgi, K. | Ofner, S. | Musick, B. | +5

3

Associations of HIV and Depression with Incident Diabetes Mellitus : Veterans Aging Cohort Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Bourgi, K. | Kundu, S. | Stewart, J. | +3

4

Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Leonard, M. | Cindi, Z. | Bradford, Y. | +17

5

Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Rebeiro, P. | Jenkins, C. | Bian, A. | +20

6

Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

enthalten in: Journal of the International AIDS Society | 2020

von Bourgi, K. | Jenkins, C. | Rebeiro, P. | +21

7

Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Bourgi, K. | Rebeiro, P. | Turner, M. | +5

CommentIn: Clin Infect Dis. 2020 Mar 17;70(7):1275-1277. - PMID 31100105

8

Tennessee Healthcare Provider Practices, Attitudes, and Knowledge Around HIV Pre-Exposure Prophylaxis

enthalten in: Journal of primary care & community health | 2020

von Moore, E. | Kelly, S. | Alexander, L. | +9

9

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

enthalten in: Journal of the International AIDS Society | 2020

von Bourgi, K. | Jenkins, C. | Rebeiro, P. | +21

10

Inflammation and Metabolic Complications in HIV

enthalten in: Current HIV/AIDS reports | 2018

von Bourgi, K. | Wanjalla, C. | Koethe, J.